Antimicrobial mechanism of lantibiotics

Mohammad R. Islam, Jun Ichi Nagao, Takeshi Zendo, Kenji Sonomoto

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Lantibiotics are ribosomally synthesized antimicrobial peptides that commonly target the cell wall precursor lipid II during their antimicrobial mechanism and exert their inhibitory activity by (i) inhibition of cell wall biosynthesis, and (ii) stable pore formation in the target membrane. Type-A(I) (i.e. nisin) and two-component (i.e. lacticin 3147) lantibiotics initially interact with lipid II to stabilize the complex, which then proceeds to inhibit cell wall biosynthesis and pore formation. Type-A(II) (i.e. nukacin ISK-1) and type-B (i.e. mersacidin) lantibiotics also use lipid II as a docking molecule, but can only inhibit cell wall biosynthesis without forming pores. In the present paper, we review the antimicrobial mechanism of different types of lantibiotics, their current progress and future prospect.

Original languageEnglish
Pages (from-to)1528-1533
Number of pages6
JournalBiochemical Society Transactions
Volume40
Issue number6
DOIs
Publication statusPublished - Dec 1 2012

Fingerprint

Bacteriocins
Cell Wall
Biosynthesis
Cells
Nisin
Membranes
Peptides
Molecules
muramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenol

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

Antimicrobial mechanism of lantibiotics. / Islam, Mohammad R.; Nagao, Jun Ichi; Zendo, Takeshi; Sonomoto, Kenji.

In: Biochemical Society Transactions, Vol. 40, No. 6, 01.12.2012, p. 1528-1533.

Research output: Contribution to journalArticle

Islam, MR, Nagao, JI, Zendo, T & Sonomoto, K 2012, 'Antimicrobial mechanism of lantibiotics', Biochemical Society Transactions, vol. 40, no. 6, pp. 1528-1533. https://doi.org/10.1042/BST20120190
Islam, Mohammad R. ; Nagao, Jun Ichi ; Zendo, Takeshi ; Sonomoto, Kenji. / Antimicrobial mechanism of lantibiotics. In: Biochemical Society Transactions. 2012 ; Vol. 40, No. 6. pp. 1528-1533.
@article{0f3d620390074b3695af7b29f505ca09,
title = "Antimicrobial mechanism of lantibiotics",
abstract = "Lantibiotics are ribosomally synthesized antimicrobial peptides that commonly target the cell wall precursor lipid II during their antimicrobial mechanism and exert their inhibitory activity by (i) inhibition of cell wall biosynthesis, and (ii) stable pore formation in the target membrane. Type-A(I) (i.e. nisin) and two-component (i.e. lacticin 3147) lantibiotics initially interact with lipid II to stabilize the complex, which then proceeds to inhibit cell wall biosynthesis and pore formation. Type-A(II) (i.e. nukacin ISK-1) and type-B (i.e. mersacidin) lantibiotics also use lipid II as a docking molecule, but can only inhibit cell wall biosynthesis without forming pores. In the present paper, we review the antimicrobial mechanism of different types of lantibiotics, their current progress and future prospect.",
author = "Islam, {Mohammad R.} and Nagao, {Jun Ichi} and Takeshi Zendo and Kenji Sonomoto",
year = "2012",
month = "12",
day = "1",
doi = "10.1042/BST20120190",
language = "English",
volume = "40",
pages = "1528--1533",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "6",

}

TY - JOUR

T1 - Antimicrobial mechanism of lantibiotics

AU - Islam, Mohammad R.

AU - Nagao, Jun Ichi

AU - Zendo, Takeshi

AU - Sonomoto, Kenji

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Lantibiotics are ribosomally synthesized antimicrobial peptides that commonly target the cell wall precursor lipid II during their antimicrobial mechanism and exert their inhibitory activity by (i) inhibition of cell wall biosynthesis, and (ii) stable pore formation in the target membrane. Type-A(I) (i.e. nisin) and two-component (i.e. lacticin 3147) lantibiotics initially interact with lipid II to stabilize the complex, which then proceeds to inhibit cell wall biosynthesis and pore formation. Type-A(II) (i.e. nukacin ISK-1) and type-B (i.e. mersacidin) lantibiotics also use lipid II as a docking molecule, but can only inhibit cell wall biosynthesis without forming pores. In the present paper, we review the antimicrobial mechanism of different types of lantibiotics, their current progress and future prospect.

AB - Lantibiotics are ribosomally synthesized antimicrobial peptides that commonly target the cell wall precursor lipid II during their antimicrobial mechanism and exert their inhibitory activity by (i) inhibition of cell wall biosynthesis, and (ii) stable pore formation in the target membrane. Type-A(I) (i.e. nisin) and two-component (i.e. lacticin 3147) lantibiotics initially interact with lipid II to stabilize the complex, which then proceeds to inhibit cell wall biosynthesis and pore formation. Type-A(II) (i.e. nukacin ISK-1) and type-B (i.e. mersacidin) lantibiotics also use lipid II as a docking molecule, but can only inhibit cell wall biosynthesis without forming pores. In the present paper, we review the antimicrobial mechanism of different types of lantibiotics, their current progress and future prospect.

UR - http://www.scopus.com/inward/record.url?scp=84870180442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870180442&partnerID=8YFLogxK

U2 - 10.1042/BST20120190

DO - 10.1042/BST20120190

M3 - Article

C2 - 23176511

AN - SCOPUS:84870180442

VL - 40

SP - 1528

EP - 1533

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 6

ER -